National Bank of Canada FI Has $5.81 Million Position in Revvity Inc. (NYSE:RVTY)

National Bank of Canada FI increased its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 67.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 54,949 shares of the company's stock after purchasing an additional 22,053 shares during the period. National Bank of Canada FI's holdings in Revvity were worth $5,814,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. T. Rowe Price Investment Management Inc. raised its position in Revvity by 16.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock worth $2,317,170,000 after acquiring an additional 2,969,326 shares during the period. EdgePoint Investment Group Inc. raised its position in Revvity by 51.1% during the fourth quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock worth $452,939,000 after acquiring an additional 1,372,456 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Revvity by 17.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock valued at $851,764,000 after buying an additional 1,151,821 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Revvity by 15,023.0% in the first quarter. GAMMA Investing LLC now owns 287,035 shares of the company's stock valued at $30,368,000 after buying an additional 285,137 shares during the last quarter. Finally, Jennison Associates LLC acquired a new stake in Revvity during the first quarter worth about $27,282,000. Institutional investors own 86.65% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on RVTY. JPMorgan Chase & Co. lowered their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Raymond James Financial reissued an "outperform" rating and issued a $115.00 price objective (down previously from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Evercore ISI lowered their price objective on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Stifel Nicolaus lowered their price objective on shares of Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a research note on Tuesday, July 29th. Finally, Bank of America decreased their price target on shares of Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Five equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $120.07.

Revvity Stock Performance

Shares of RVTY stock traded up $1.46 during trading on Friday, reaching $90.91. The company had a trading volume of 1,268,605 shares, compared to its average volume of 1,589,488. The firm's 50 day simple moving average is $94.94 and its two-hundred day simple moving average is $100.04. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. Revvity Inc. has a one year low of $85.12 and a one year high of $129.50. The company has a market capitalization of $10.55 billion, a PE ratio of 38.52, a PEG ratio of 2.44 and a beta of 0.91.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. The company had revenue of $720.28 million for the quarter, compared to the consensus estimate of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%. The company's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.22 EPS. Sell-side analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's payout ratio is currently 11.86%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.